![[logo] HealthTree Foundation](https://static.healthtree.org/icons/icon_spinner.svg){kind=icon}
![[logo] HealthTree Foundation](https://static.healthtree.org/logo_icon_only.svg){kind=icon}
Myelodysplastic Syndromes medications
In this page you will find the list of drugs approved by the FDA to treat Myelodysplastic Syndromes.
azacitidine (Onureg, Vidaza)
Chemotherapy Agents
Learn More arrow_right_alt
darbepoetin alfa (Aranesp)
Hematinics
Learn More arrow_right_alt
decitabine (Dacogen)
Chemotherapy Agents
Learn More arrow_right_alt
Deferasirox (Exjade, Jadenu)
Iron Chelators
Learn More arrow_right_alt
Deferoxamine (Desferal)
Iron Chelators
Learn More arrow_right_alt
eltrombopag (Promacta)
Thrombopoietin Receptor Agonists
Learn More arrow_right_alt
enasidenib (Idhifa)
Targeted Therapy
Learn More arrow_right_alt
erythropoietin (Epogen, Procrit)
Hematinics
Learn More arrow_right_alt
filgrastim (Neupogen, Nivestym, Zarxio)
Leukocyte Growth Factors
Learn More arrow_right_alt
imetelstat (Rytelo)
Telomerase Inhibitors
Learn More arrow_right_alt
ivosidenib (Tibsovo)
Targeted Therapy
Learn More arrow_right_alt
lenalidomide (Revlimid)
Immunomodulatory Agents
Learn More arrow_right_alt
luspatercept (Reblozyl)
Erythroid Maturation Agents
Learn More arrow_right_alt
pegfilgrastim (Fulphila, Neulasta, Udenyca)
Leukocyte Growth Factors
Learn More arrow_right_alt
romiplostim (Nplate)
Thrombopoietin Receptor Agonists
Learn More arrow_right_alt
venetoclax (Venclexta)
Targeted Therapy
Learn More arrow_right_alt
All HealthTree resources available anywhere, anytime
Download our App
Follow Us
Download our App
HealthTree Foundation is a qualified 501(c)(3) tax-exempt organization.
Copyright © 2025 HealthTree Foundation. All rights reserved.
Tax ID 45-5354811